Cases
#1 in Business Subscribe Email Print

You are here: Home > Business > Careers Employment > Absent without Leave - Managing Absence in the Workplace

Tags

  • medical
  • possible
  • companies
  • combination products
  • companies involved
  • companies involved

  • Links

  • You Might Feel Some Slight Pressure
  • Choosing The Right Safe For Your Home Valuables
  • Questions You Should Be Asking Of Your Potential LMS Vendors - But Likely Are Not
  • Cases - Absent without Leave - Managing Absence in the Workplace

    According to the Institute of Psychiatry (April 2005), for the first time, stress, anxiety and depression have overtaken physical ailments as the most common cause of long-term absence from work. With sickness absence reportedly costing employers an average of ?522 per employee per year (or an average of 10 lost working days), there are good
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    reasons to look closely at the root causes of absenteeism and, where possible, provide early intervention to support employees in regaining their health.

    Short-term absence

    Short-term absence is usually defined as a period of absence of less than ten consecutive working days, and will usually be as a result of the employee suffering from
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    minor medical condition.

    Persistent short-term sickness is one of the most common problems employers have to face. Arranging temporary cover when an employee is off sick may not always be viable, and is often both disruptive and costly. Many employers therefore adopt the approach of persuading existing employees to cover for absentees on a
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    n ad hoc basis.

    While this may work in the short term, when applied over longer periods it puts pressure on existing staff, as they struggle to do their own work in addition to that of an absent colleague. The effect of this on staff morale can be damaging and counterproductive. Staff frequently feel resentful if required to do two jobs - o
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    ten within the same timescale and for no extra remuneration. The situation may be further compounded when the absentee employee returns to work and is met with resentment from those who have had to cover for them during their absence.

    Long-term absence

    Long-term absence is defined as any period of absence in excess of ten consecutive worki
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    ng days. Such absence - particularly where it is stress-related - presents a different problem for employers. In the short-term they may feel able to cover an absence internally, whereas in the longer term it may be necessary to recruit temporary staff who will normally require induction training and may not necessarily fit in well with exis
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    ing teams. Temporary staff will also increase the salaries and wages bill, as well as involving the payment of costly agency fees.

    After a long-term absence, a phased return to work will most certainly be recommended, with possible training needed to support the employee ‘back into work’. Where rehabilitation is not an option, the costs of
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    premature retirement due to ill-health will also need to be taken into account. Stress therefore has a quantifiable impact not only on health, safety and individual well being, but on the operational and financial performance of the organisation as a whole.

    Attendance patterns

    The link between stress and absence is so well proven that stat
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    stics on non-attendance are often used as an indicator of stress ‘hot spots’ within an organisation. These figures may also be used to measure the effectiveness of stress management interventions.

    In the analysis of attendance patterns, any extended periods of sick leave will immediately be apparent. Obviously, a stress-related illness or i
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    njury cannot be ‘undone’, but positive steps can still be taken by actively managing the return to work of the employee, and to minimise the risk of any identified stress reoccurring.

    Of even more importance is the monitoring of short-term absences that may be the first sign of excessive pressure. Typically, absences that tend to fall into
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    pattern (e.g. if an employee is off sick every Monday), or are linked to particular operational requirements (such as reporting periods) are the most likely to be stress-related. It’s therefore important to look initially at the pattern of absence, rather than the reasons given for it.

    Stress is typically under-reported as a reason for abs
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    ence - especially in the early stages - with alternatives such as colds, back pain, migraine or general fatigue being given instead. This under-reporting can occur for a number of reasons. For example, it may be that the individual has not recognised that they might be suffering from stress, or they may be reluctant to admit, either to other
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    or themselves, that this is the real problem. There is often a stigma attached to stress, related to a perceived inadequacy or inability to cope. This exacerbates the problem by creating an artificial barrier to its identification and management.

    Absence management

    A successful absence management policy will ideally create a culture enabl
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    ing any individual to admit to stress-related ill-health, without feeling that their future employment or career prospects may be damaged. Clearly, the earlier that specific sources of stress are identified, the sooner appropriate action can be taken to reduce the poor attendance that often ensues.

    In order to establish a level of control o
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    er sickness absence, and to implement an effective policy, it’s advisable to analyse employee data including the following:

    • The number of days lost per year.

    • The number of employees taking leave of absence.

    • The average length of absence per employee.

    • The employees and department(s) with the worst - and best - record of absence.

    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    • Are there any identifiable absence patterns?

    • Is absence influenced, for example, by age, gender, the number of years in the job or seasonal variations?

    • How many employees take their maximum paid sickness entitlement in a year?

    • Who takes the greater proportion of sick leave or other absence during the year –workers, staff or manage
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    ent?

    The reasons for the various types and frequency of absence should then be assessed, including the following:

    • Is a particular job too stressful or too boring?

    • Is the work dangerous or does it require too much physical effort?

    • Is the working environment unsuitable?

    • Is management weak or over-aggressive?

    • Is morale poor?

    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    Is there a culture of taking days off at particular times?

    • Do working practices lack organisational support?

    • Is there a general lack of incentive and motivation?

    When all this information has been collated and analysed, it can then be used to devise policies and procedures in consultation with staff representatives that should, when p
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    operly implemented, substantially reduce the incidence of absence.

    Carole Spiers Group

    International Stress Management & Employee Wellbeing Consultancy

    Gordon House, 83-85 Gordon Ave, Stanmore, Middlesex. HA7 3QR. UK

    Tel: +44(0) 20 8954 1593 Fax: +44(0) 20 8907 9290

    Email: info@carolespier
    sgroup.com www.carolespiersgroup.com

    If you would like to book Carole as a keynote speaker or conference chair at your next conference - check out www.carolespiersgroup.com/mediaenquirysheet.php


    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.cases.org.ua/article/11387/cases-Absent-without-Leave--Managing-Absence-in-the-Workplace.html">Absent without Leave - Managing Absence in the Workplace</a>

    BB link (for phorums):
    [url=http://www.cases.org.ua/article/11387/cases-Absent-without-Leave--Managing-Absence-in-the-Workplace.html]Absent without Leave - Managing Absence in the Workplace[/url]

    Related Articles:

    Don't Gamble With Your Business

    Can Sending Business Christmas Cards Really Be Effective

    Signage and Branding for the Small Business

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com